These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 886069)

  • 21. Patterns of changes in peripheral blood composition in the course of combination chemotherapy of cancer.
    Jedrzejczak WW; Siekierzyński M; Czarnecki C; Dziuk E
    Strahlentherapie; 1976 Nov; 152(5):469-76. PubMed ID: 996891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial of heparin and cyclophosphamide (NSC-26271) in the treatment of lung cancer.
    Edlis HE; Goudsmit A; Brindley C; Niemetz J
    Cancer Treat Rep; 1976 May; 60(5):575-8. PubMed ID: 991145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
    Naumann R
    Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Excretion of thiophosphamide and cyclophosphane in lung cancer patients].
    Kas'ianenko IV; Pivniuk VM
    Vopr Onkol; 1974 Oct; 20(7):28-31. PubMed ID: 4212652
    [No Abstract]   [Full Text] [Related]  

  • 30. Small cell cancer of lung; rapid tumor necrosis leading to serious pulmonary infections after intensive chemotherapy.
    Brandman JR; Ruckdeschel JC; O'Donnell MR; Horton J
    N Y State J Med; 1981 Aug; 81(9):1332-4. PubMed ID: 6267528
    [No Abstract]   [Full Text] [Related]  

  • 31. [The combined chemotherapy with vincristine, prospidin, bleomycin and cyclophosphane of epidermoid lung cancer].
    Dudareva LA
    Vopr Onkol; 1990; 36(9):1092-5. PubMed ID: 1700549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
    Seccia A; Scafuri L; Scognamillo A; Cocco G
    G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355
    [No Abstract]   [Full Text] [Related]  

  • 33. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment including postoperative chemotherapy in lung cancer patients.
    Trakhtenberg AKh; Zakharchenkov AV; Zhiglov MA; Glagolev AN; Kovalev VN; Amiraliev MA; Barchuk AS; Malay EF; Vidyak IV; Grigoryeva SP
    Neoplasma; 1988; 35(3):351-8. PubMed ID: 3405343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group.
    Bando H; Takishita Y; Ogura T; Sone S; Shimizu E; Nakayama T; Doi H; Kobayashi M
    Jpn J Clin Oncol; 1991 Dec; 21(6):435-9. PubMed ID: 1666660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.
    Bregni M; Siena S; Ravagnani F; Bonadonna G; Gianni AM
    Haematologica; 1990; 75 Suppl 1():95-8. PubMed ID: 2190885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Knost JA; Greco FA; Hande KR; Richardson RL; Fer MF; Oldham RK
    Cancer Treat Rep; 1981; 65(11-12):941-5. PubMed ID: 7028255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small cell carcinoma of the lung: rapid development of acute leukemia.
    Jackson DV; Cruz JM; Woodruff R
    N C Med J; 1983 Aug; 44(8):475-6. PubMed ID: 6314156
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug induced pulmonary disease. Diffuse interstitial pneumonitis during chemoradiotherapy for small cell carcinoma of the lung. Two cases (author's transl)].
    Riou R; Duvillard P; Touraine R
    Poumon Coeur; 1982; 38(1):57-62. PubMed ID: 6283505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide effect on changes in rabbit peripheral blood in the development period.
    Maślińska D; Swierczyńska A; Koch I
    Acta Physiol Pol; 1983; 34(1):85-90. PubMed ID: 6637534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.